[1] MIQUEL S, CHAMP C, DAY J, et al. Poor cognitive ageing:vulnerabilities, mechanisms and the impact of nutritional interventions[J]. Ageing Res Rev, 2018, 42:40-55.
[2] CHAN K Y, WANG W, WU J J, et al. Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010:a systematic review and analysis[J]. Lancet, 2013, 381(9882):2016-2023.
[3] KANG E, WEN Z, SONG H, et al. Adult neurogenesis and psychiatric disorders[J]. Cold Spring Harb Perspect Biol, 2016, 8(9):a019026.
[4] ERNST A, ALKASS K, BERNARD S, et al. Neurogenesis in the striatum of the adult human brain[J]. Cell, 2014, 156(5):1072-1083.
[5] ALI T, BADSHAH H, KIM T H, et al. Melatonin attenuates D-galactose-induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NF-K B/JNK signaling pathway in aging mouse model[J]. J Pineal Res, 2015, 58(1):71-85.
[6] VORHEES C V, WILLIAMS M T. Morris water maze:procedures for assessing spatial and related forms of learning and memory[J]. Nat Protoc, 2006, 1(2):848-858.
[7] MIYAMOTO T, STEIN L, THOMAS R, et al. Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture[J]. Molecul Neurodegen, 2017, 12(1):41.
[8] HUSAIN M, MEHTA M A. Cognitive enhancement by drugs in health and disease[J]. Trends Cogn Sci (Regul Ed), 2011, 15(1):28-36.
[9] SHWE T, PRATCHAYASAKUL W, CHATTIPAKORN N, et al. Role of D-galactose-induced brain aging and its potential used for therapeutic interventions[J]. Exp Gerontol, 2017, 101:13-36.
[10] WEI H, LI L, SONG Q, et al. Behavioural study of the D-galactose induced aging model in C57BL/6J mice.[J]. Behav Brain Res, 2005, 157(2):245-251.
[11] SADIGHETEGHAD S, MAJDI A, MCCANN S K, et al. D-galactose-induced brain ageing model:a systematic review and Meta-analysis on cognitive outcomes and oxidative stress indices[J]. Plos One, 2017, 12(8):e0184122.